Moreover, these factors activate the expression of osteoblast stimulatory factors by prostate cancer cells, including VEGF, platelet-derived growth factor, bone morphogenic protein-2, insulin-like growth factor-1, and endothelin-1 [23–25]. This evidence concerns the gene VEGFA and prostate carcinoma.